CD8A and glioblastoma: Human eosinophils in an in vitro study have also been reported to be responsive to S100B [83], a possible blood marker in some GBM cases that is known to be released by CD8+ T cells, astrocytes, oligodendrocytes, and tumor cells [84-86].